Non Surgical Protocol for Treatment of Mucositis
1 other identifier
interventional
75
1 country
1
Brief Summary
Peri-implant mucositis is an important disease entity as a result of its high prevalence and the lack of a standard mode of therapy. Non-surgical therapy of peri-implant mucositis appears to be partially effective in resolving the disease. In several cases, however, only limited improvements have been reported in the main clinical parameters (bleeding partial resolution and presence of pocket at follow-up visits) and there is a clear tendency to relapse of the disease. In these cases it is therefore recommended to consider adjunctive therapies. Numerous approaches have been used for implant surface decontamination including mechanical, chemical and treatments by means of air-powder or laser. The aim of the present randomized controlled clinical trial will be to assess the efficacy in improving clinical parameters of two further methods of implant surface decontamination (Er:YAG laser or air-abrasive device) after mechanical cleaning during non surgical treatment of peri-implant mucositis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2019
CompletedFirst Posted
Study publicly available on registry
May 15, 2019
CompletedStudy Start
First participant enrolled
July 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2022
CompletedMarch 3, 2023
February 1, 2023
2.5 years
May 14, 2019
February 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bleeding on probing changes
changes of bleeding on probing, evaluated as present if bleeding will be evident within 30 s after probing, or absent, if no bleeding will be noticed within 30 s after probing
baseline, 1, 3, 6 months
Secondary Outcomes (4)
probing pocket depth changes
baseline, 1, 3, 6 months
mucosal recession changes
baseline, 1, 3, 6 months
clinical attachment level changes
baseline, 1, 3, 6 months
complete disease resolution (percentage)
6 months
Study Arms (3)
Mechanical debridement with curettes
SHAM COMPARATORmechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments
Er:YAG laser
EXPERIMENTALEr:YAG laser treatment will be provided on the implant/abutment surface.
Air Powder
ACTIVE COMPARATORan Air-Powder treatment will be provided on the implant/abutment surface.
Interventions
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments. Furthermore, an Er:YAG laser will be used for the implant surface decontamination.
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments. Furthermore, an Air-Powder treatment will be provided on the implant/abutment surface.
Eligibility Criteria
You may qualify if:
- presence of at least one screw-type titanium implant exhibiting bleeding and/or suppuration on probing combined without progressive radiographic bone loss (compared to crestal bone levels at the time of placement of the reconstruction)or \<3mm bone level
- single tooth and bridgework restorations without overhangings
- no evidence of occlusal overload (i.e. occlusal contacts revealed appropriate adjustment)
- implant function time ≥ 1 year
You may not qualify if:
- Patients with uncontrolled diabetes
- patients with osteoporosis or under bisphosphonate medication,
- pregnant or lactating women,
- patients with a history of radiotherapy to the head and neck region
- patients with incapability to perform basal oral hygiene measures due to physical or mental disorders
- hollow implants
- implant mobility
- implants at which no position could be identified where proper probing measurements could be performed;
- previous surgical treatment of the peri-implantitis lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Università Vita-Salute San Raffaele
Milan, 20100, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Massimo De Sanctis
Università Vita-Salute San Raffaele
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 14, 2019
First Posted
May 15, 2019
Study Start
July 2, 2019
Primary Completion
January 16, 2022
Study Completion
July 27, 2022
Last Updated
March 3, 2023
Record last verified: 2023-02